Guy Fish, MD, has more than 25 years of health care, life sciences, and biotechnology experience. He serves as CEO and is a board member of Cellanyx, a life sciences company.
Previously, Dr. Fish served as senior vice president of the healthcare practice group at Fletcher Spaght. Prior to that role, he was vice president of business development at Collagenesis, a tissue-engineering firm; a securities analyst in the medical devices sector for Sanford Bernstein; a health care consultant at The Boston Consulting Group; and a solo practice physician.
Dr. Fish holds an MBA from the Yale School of Management, an MD from the Yale School of Medicine, a board certification in internal medicine, and an AB in biochemistry from Harvard College. He is a member of the Board of Directors of Phase Biosciences, Metabolon, and BIOCIUS and serves as an observer of the Board of Proteus Biomedical.
Dr. Fish is a Trustee of Beth Israel Deaconess Medical Center, Chairman of the Licensing Board for Dubai Health Care, and former Chairman of the Licensing Committee for the Board of Registration in Medicine for the Commonwealth of Massachusetts.